About Sun Pharma
Sun Pharma is a company based in Mumbai (India) founded in 1983 by Dilip Shanghvi. The company has 25,870 employees as of March 31, 2024. Sun Pharma has completed 19 acquisitions, including Biosynthesis, Caraco Pharmaceutical Laboratories and Chattem Chemicals.
- Headquarter Mumbai, India
- Employees 25870 as on 31 Mar, 2024
- Founders Dilip Shanghvi
- Stage Public
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Sun Pharmaceutical Industries Limited
-
Annual Revenue
$6.1 B (USD)8.96as on Mar 31, 2025
-
Net Profit
$1.28 B (USD)14.12as on Mar 31, 2025
-
EBITDA
$1.76 B (USD)23.83as on Mar 31, 2025
-
Latest Funding Round
Not available
-
Investors
Not available
-
Employee Count
25870
as on Mar 31, 2024
-
Investments & Acquisitions
Biosynthesis
& 18 more
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of Sun Pharma
Sun Pharma is a publicly listed company on the NSE with ticker symbol SUNPHARMA in India, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
People of Sun Pharma
Unlock access to complete
Unlock access to complete
Funding Insights of Sun Pharma
Detailed funding history for Sun Pharma
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Sun Pharma
Sun Pharma has strategically engaged in corporate development activities, having acquired 19 companies. Notable acquisitions include Biosynthesis, Caraco Pharmaceutical Laboratories and Chattem Chemicals.
Investment portfolio details for Sun Pharma
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Generic drugs are manufactured by Libra Merger in Israel.
|
Locked | Locked | 2023 | Locked | |
|
Immuno-oncology treatments for solid tumors are developed and commercialized.
|
Locked | Locked | 2014 | Locked | |
|
Developer of nutraceuticals and functional foods
|
Locked | Locked | 2014 | Locked |
Complete acquisition details for Sun Pharma
Transaction dates, acquired stakes, disclosed values, domains, and locations require an active premium plan.
- Transaction dates
- Acquired stakes
- Disclosed values
- Domains and locations
Verified entity values are shown only after access is granted.
Financial Statements - Sun Pharma
Detailed financials for Sun Pharma
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Sun Pharma Comparisons
Peer comparison for Sun Pharma
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Sun Pharma
Detailed competitors of Sun Pharma
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Sun Pharma
Complete news archive for Sun Pharma
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Sun Pharma
Sun Pharma was founded in 1983.
Sun Pharma is headquartered in Mumbai, India. It is registered at Mumbai, Maharashtra, India.
As of Mar 31, 2024, the latest employee count at Sun Pharma is 25,870.
Annual revenue of Sun Pharma is $6.1B as on Mar 31, 2025.
Sun Pharma was founded in 1983 in Mumbai, India, as a specialty generic pharmaceutical entity. Formulations and active pharmaceutical ingredients are produced and distributed across therapeutic areas including psychiatry, neurology, cardiology, diabetology, gastroenterology, gynaecology, nephrology, urology, and oncology. Dosage forms encompass tablets, capsules, injectables, inhalers, ointments, creams, and liquids. In 2022, annual revenues reached 5.39 billion with net profits at 0.54 billion.
Yes, Sun Pharma is publicly traded on NSE under the ticker symbol SUNPHARMA.
Sun Pharma has made 19 acquisitions, including Biosynthesis, Caraco Pharmaceutical Laboratories, and Chattem Chemicals.
The ticker symbol of Sun Pharma is SUNPHARMA on NSE.